AllRock Bio
PrivateLast Round
Series A
Sep 16, 2025
Est. Valuation
$67M
Total Funding Raised
$50M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AllRock Bio is a biotechnology company developing therapies for cardiopulmonary and fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AllRock Bio Comparables
Compare AllRock Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Redx Pharma Plc | 36% | |
| tiakis Biotech AG | 34% | |
| MBQ Pharma | 34% |
AllRock Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 16, 2025 |
Key People
Founding team and executive leadership
AllRock Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Westlake Village BioPartners | Series A |
| Versant Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 30, 2026
Monthly visitors increased 36% MoM.
- Nov 15, 2025
Grew 240% QoQ from 5 to 17 employees.
AllRock Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AllRock Bio's valuation, stock price, and market status.
Is AllRock Bio a public or private company?
AllRock Bio is a private company.
What is the current stock price of AllRock Bio?
AllRock Bio is a private company, so its shares have no public market price. Caplight tracks AllRock Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AllRock Bio worth (valuation)?
AllRock Bio's valuation is estimated at $67.0M based on funding round data.
Can I buy AllRock Bio stock?
AllRock Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AllRock Bio's last funding round?
AllRock Bio's most recent funding round was Series A on September 16, 2025.
Who are the main investors in AllRock Bio?
Key investors in AllRock Bio include Westlake Village BioPartners, Versant Ventures.
Will AllRock Bio IPO soon?
No public IPO plans have been announced for AllRock Bio.
How can I track AllRock Bio secondary market activity?
Caplight tracks bids, offers, and trades in AllRock Bio's shares on secondary markets.